Ziegler Capital Management, LLC Jounce Therapeutics, Inc. Transaction History

Ziegler Capital Management, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 21, 2022	SELL	$2.8 - $7.67 $142,648 - $390,755	-50,946 Closed	0 $0
Q4 2021 Feb 09, 2022	SELL	$7.11 - $9.64 $126,799 - $171,919	-17,834 Reduced 25.93%	50,946 $425,000
Q3 2021 Oct 27, 2021	SELL	$5.04 - $8.73 $11,677 - $20,227	-2,317 Reduced 3.26%	68,780 $511,000
Q2 2021 Jul 21, 2021	BUY	$6.58 - $10.66 $467,818 - $757,894	71,097 New	71,097 $483,000
Q1 2021 Apr 29, 2021	SELL	$6.73 - $13.87 $337,980 - $696,551	-50,220 Closed	0 $0
Q4 2020 Feb 05, 2021	SELL	$6.37 - $10.33 $37,213 - $60,347	-5,842 Reduced 10.42%	50,220 $352,000
Q3 2020 Oct 21, 2020	BUY	$4.58 - $10.95 $256,763 - $613,878	56,062 New	56,062 $457,000

720K

Ticker JNCE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 51,694,200
Description
Jounce Therapeutics, Inc., a clinical-stage immunotherapy company, develops therapies for the treatment of cancer. The company develops vopratelimab, a clinical-stage monoclonal antibody, which is in Phase II clinical trial that binds to and activates the Inducible T cell CO-Stimulator, a protein on the surface of T cells found in various solid ...

Get notified when there are updates to the investment portfolio of Ziegler Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Ziegler Capital Management, LLC with notifications on news.